Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Cytosorbents Corporation - SIC # 3840 -
Ticker
Exchange
SIC #
Website
Latest Ticker
CTSO
Nasdaq
3840
www.cytosorbents.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Cytosorbents Corporation
CTSO: CytoSorbents Reports Strong 4th Quarter and Full Year 2025 Results
- Apr 6th, 2026 3:42 am
Cytosorbents (CTSO) Q4 2025 Earnings Transcript
- Mar 26th, 2026 8:40 am
Cytosorbents Corporation Q4 2025 Earnings Call Summary
- Mar 26th, 2026 6:30 am
CytoSorbents Corp (CTSO) Q4 2025 Earnings Call Highlights: Navigating Growth and Regulatory ...
- Mar 25th, 2026 9:01 pm
CytoSorbents: Q4 Earnings Snapshot
- Mar 25th, 2026 2:33 pm
CytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
- Mar 25th, 2026 2:03 pm
CytoSorbents Announces HotSwap™ Launch, Renewed Aferetica Partnership, and New Clinical Evidence at ISICEM 2026
- Mar 19th, 2026 7:30 am
CytoSorbents to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
- Mar 5th, 2026 5:00 am
Analysts Expect Breakeven For Cytosorbents Corporation (NASDAQ:CTSO) Before Long
- Feb 14th, 2026 5:16 am
CTSO: CytoSorbents Price Target Increased to $5.00 Based on Higher Than Expected Gross Margins
- Jan 13th, 2026 6:08 am
CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Results and Business Update
- Jan 12th, 2026 5:00 am
CytoSorbents to Participate in a Virtual Fireside Chat with D. Boral Capital on Monday, December 15, 2025
- Dec 10th, 2025 5:00 am
Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in London
- Nov 17th, 2025 3:42 pm
CTSO: CytoSorbents High Margin Revenue Growth Supports Price Target of $4.00
- Nov 17th, 2025 2:21 am
CytoSorbents Corp (CTSO) Q3 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ...
- Nov 13th, 2025 10:03 pm
Cytosorbents (CTSO) Q3 2025 Earnings Transcript
- Nov 13th, 2025 3:14 pm
CytoSorbents: Q3 Earnings Snapshot
- Nov 13th, 2025 2:58 pm
CytoSorbents Reports Third Quarter 2025 Financial Results and Provides Business Update
- Nov 13th, 2025 2:05 pm
CytoSorbents to Participate at the Jefferies Global Healthcare Conference in London
- Nov 11th, 2025 5:00 am
CytoSorbents to Report Third Quarter 2025 Financial Results and Recent Business Highlights
- Oct 30th, 2025 5:00 am
Scroll